Literature DB >> 11429413

Structure and activity of the insect cytokine growth-blocking peptide. Essential regions for mitogenic and hemocyte-stimulating activities are separate.

T Aizawa1, Y Hayakawa, A Ohnishi, N Fujitani, K D Clark, M R Strand, K Miura, N Koganesawa, Y Kumaki, M Demura, K Nitta, K Kawano.   

Abstract

Growth-blocking peptide (GBP) is a 25-amino acid insect cytokine found in Lepidopteran insects that possesses diverse biological activities such as larval growth regulation, cell proliferation, and stimulation of immune cells (plasmatocytes). The tertiary structure of GBP consists of a structured core that contains a disulfide bridge and a short antiparallel beta-sheet (Tyr(11)-Arg(13) and Cys(19)-Pro(21)) and flexible N and C termini (Glu(1)-Gly(6) and Phe(23)-Gln(25)). In this study, deletion and point mutation analogs of GBP were synthesized to investigate the relationship between the structure of GBP and its mitogenic and plasmatocyte spreading activity. The results indicated that deletion of the N-terminal residue, Glu(1), eliminated all plasmatocyte spreading activity but did not reduce mitogenic activity. In contrast, deletion of Phe(23) along with the remainder of the C terminus destroyed all mitogenic activity but only slightly reduced plasmatocyte spreading activity. Therefore, the minimal structure of GBP containing mitogenic activity is 2-23 GBP, whereas that with plasmatocyte spreading activity is 1-22 GBP. NMR analysis indicated that these N- and C-terminal deletion mutants retained a similar core structure to wild-type GBP. Replacement of Asp(16) with either a Glu, Leu, or Asn residue similarly did not alter the core structure of GBP. However, these mutants had no mitogenic activity, although they retained about 50% of their plasmatocyte spreading activity. We conclude that specific residues in the unstructured and structured domains of GBP differentially affect the biological activities of GBP, which suggests the possibility that multifunctional properties of this peptide may be mediated by different forms of a GBP receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429413     DOI: 10.1074/jbc.M105251200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  C-terminal elongation of growth-blocking peptide enhances its biological activity and micelle binding affinity.

Authors:  Yoshitaka Umetsu; Tomoyasu Aizawa; Kaori Muto; Hiroko Yamamoto; Masakatsu Kamiya; Yasuhiro Kumaki; Mineyuki Mizuguchi; Makoto Demura; Yoichi Hayakawa; Keiichi Kawano
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

2.  Bombyxin stimulates proliferation of cultured stem cells derived from heliothis virescens and mamestra brassicae larvae1.

Authors:  Shintaro Goto; Marcia J Loeb; Makio Takeda
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Jan-Feb       Impact factor: 2.416

3.  Adaptor protein is essential for insect cytokine signaling in hemocytes.

Authors:  Yasunori Oda; Hitoshi Matsumoto; Maiko Kurakake; Masanori Ochiai; Atsushi Ohnishi; Yoichi Hayakawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

4.  A sand fly salivary protein acts as a neutrophil chemoattractant.

Authors:  Anderson B Guimaraes-Costa; John P Shannon; Ingrid Waclawiak; Jullyanna Oliveira; Claudio Meneses; Waldione de Castro; Xi Wen; Joseph Brzostowski; Tiago D Serafim; John F Andersen; Heather D Hickman; Shaden Kamhawi; Jesus G Valenzuela; Fabiano Oliveira
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

5.  Response to Dengue virus infections altered by cytokine-like substances from mosquito cell cultures.

Authors:  Nipaporn Kanthong; Chaowanee Laosutthipong; Timothy W Flegel
Journal:  BMC Microbiol       Date:  2010-11-16       Impact factor: 3.605

6.  Nitric oxide mediates antimicrobial peptide gene expression by activating eicosanoid signaling.

Authors:  Md Sadekuzzaman; Yonggyun Kim
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.